| cellular component assembly involved in morphogenesis | GO:0010927 | 139 | 0.828 | |
| ribonucleoside triphosphate metabolic process | GO:0009199 | 220 | 0.827 | Rat |
| muscle cell differentiation | GO:0042692 | 261 | 0.796 | |
| protein localization to membrane | GO:0072657 | 108 | 0.733 | Human |
| aromatic compound catabolic process | GO:0019439 | 286 | 0.656 | Rat |
| actin cytoskeleton organization | GO:0030036 | 220 | 0.653 | Mouse |
| purine ribonucleoside triphosphate metabolic process | GO:0009205 | 220 | 0.652 | Rat |
| ribonucleoside triphosphate catabolic process | GO:0009203 | 199 | 0.644 | Rat |
| purine ribonucleoside catabolic process | GO:0046130 | 205 | 0.637 | Rat |
| carbohydrate derivative catabolic process | GO:1901136 | 231 | 0.634 | Rat |
| membrane organization | GO:0061024 | 245 | 0.628 | Human |
| muscle cell development | GO:0055001 | 133 | 0.600 | |
| nucleoside phosphate catabolic process | GO:1901292 | 222 | 0.597 | Rat |
| nucleoside triphosphate metabolic process | GO:0009141 | 230 | 0.582 | Rat |
| purine ribonucleotide metabolic process | GO:0009150 | 290 | 0.569 | Rat |
| glycosyl compound catabolic process | GO:1901658 | 206 | 0.564 | Rat |
| nucleoside phosphate metabolic process | GO:0006753 | 338 | 0.548 | Rat |
| purine containing compound metabolic process | GO:0072521 | 311 | 0.521 | Rat |
| purine nucleoside metabolic process | GO:0042278 | 241 | 0.512 | Rat |
| ribonucleotide metabolic process | GO:0009259 | 291 | 0.509 | Rat |
| hemostasis | GO:0007599 | 78 | 0.505 | |
| actomyosin structure organization | GO:0031032 | 56 | 0.502 | |
| ribonucleotide catabolic process | GO:0009261 | 208 | 0.499 | Rat |
| nucleoside catabolic process | GO:0009164 | 206 | 0.481 | Rat |
| purine nucleoside triphosphate metabolic process | GO:0009144 | 226 | 0.481 | Rat |
| glycosyl compound metabolic process | GO:1901657 | 246 | 0.474 | Rat |
| cell adhesion | GO:0007155 | 329 | 0.471 | Mouse |
| purine nucleoside triphosphate catabolic process | GO:0009146 | 203 | 0.457 | Rat |
| regulation of actin filament based process | GO:0032970 | 99 | 0.446 | Mouse |
| nucleoside metabolic process | GO:0009116 | 246 | 0.413 | Rat |
| regulation of hydrolase activity | GO:0051336 | 246 | 0.410 | |
| regulation of actin cytoskeleton organization | GO:0032956 | 84 | 0.408 | Mouse |
| digestive system development | GO:0055123 | 200 | 0.401 | |
| nucleotide catabolic process | GO:0009166 | 217 | 0.396 | Rat |
| single organismal cell cell adhesion | GO:0016337 | 131 | 0.396 | |
| organonitrogen compound catabolic process | GO:1901565 | 264 | 0.386 | Rat |
| striated muscle cell development | GO:0055002 | 125 | 0.376 | |
| actin filament organization | GO:0007015 | 113 | 0.371 | |
| purine containing compound catabolic process | GO:0072523 | 213 | 0.368 | Rat |
| endomembrane system organization | GO:0010256 | 147 | 0.366 | |
| regulation of cell migration | GO:0030334 | 219 | 0.366 | Human Mouse |
| nucleoside triphosphate catabolic process | GO:0009143 | 205 | 0.341 | Rat |
| apoptotic signaling pathway | GO:0097190 | 306 | 0.340 | |
| cellular nitrogen compound catabolic process | GO:0044270 | 280 | 0.337 | Rat |
| purine nucleoside monophosphate catabolic process | GO:0009128 | 58 | 0.334 | Rat |
| epithelial cell development | GO:0002064 | 159 | 0.319 | Mouse |
| purine ribonucleoside metabolic process | GO:0046128 | 241 | 0.312 | Rat |
| organelle assembly | GO:0070925 | 177 | 0.311 | |
| heterocycle catabolic process | GO:0046700 | 280 | 0.302 | Rat |
| ribonucleoside metabolic process | GO:0009119 | 245 | 0.297 | Rat |
| cellular amine metabolic process | GO:0044106 | 44 | 0.295 | |
| purine nucleoside catabolic process | GO:0006152 | 205 | 0.294 | Rat |
| nucleoside monophosphate catabolic process | GO:0009125 | 59 | 0.289 | Rat |
| cellular response to salt stress | GO:0071472 | 1 | 0.282 | |
| positive regulation of cellular amino acid metabolic process | GO:0045764 | 3 | 0.281 | |
| ras protein signal transduction | GO:0007265 | 77 | 0.276 | |
| organophosphate catabolic process | GO:0046434 | 232 | 0.273 | Rat |
| regulation of intracellular transport | GO:0032386 | 159 | 0.273 | Human |
| cell junction organization | GO:0034330 | 77 | 0.266 | Human |
| kidney development | GO:0001822 | 213 | 0.246 | Mouse |
| intracellular protein transport | GO:0006886 | 204 | 0.245 | Human |
| digestive tract development | GO:0048565 | 190 | 0.244 | |
| response to osmotic stress | GO:0006970 | 21 | 0.244 | |
| myotube differentiation | GO:0014902 | 105 | 0.243 | |
| positive regulation of cell motility | GO:2000147 | 116 | 0.242 | Human Mouse |
| negative regulation of protein phosphorylation | GO:0001933 | 126 | 0.239 | |
| myofibril assembly | GO:0030239 | 34 | 0.239 | |
| regulation of cellular amine metabolic process | GO:0033238 | 20 | 0.238 | |
| wound healing | GO:0042060 | 157 | 0.236 | |
| negative regulation of phagocytosis | GO:0050765 | 4 | 0.229 | |
| cellular amino acid metabolic process | GO:0006520 | 103 | 0.225 | |
| syncytium formation | GO:0006949 | 43 | 0.223 | |
| digestive tract morphogenesis | GO:0048546 | 147 | 0.220 | |
| positive regulation of cellular amine metabolic process | GO:0033240 | 5 | 0.220 | |
| regulation of cellular ketone metabolic process | GO:0010565 | 66 | 0.218 | |
| muscle fiber development | GO:0048747 | 76 | 0.218 | |
| atp metabolic process | GO:0046034 | 75 | 0.216 | Rat |
| regulation of protein kinase activity | GO:0045859 | 232 | 0.213 | |
| purine nucleotide catabolic process | GO:0006195 | 211 | 0.208 | Rat |
| actin polymerization or depolymerization | GO:0008154 | 54 | 0.207 | |
| cation transport | GO:0006812 | 399 | 0.204 | |
| calcium ion transport | GO:0006816 | 159 | 0.204 | |
| nucleotide metabolic process | GO:0009117 | 332 | 0.203 | Rat |
| protein localization to plasma membrane | GO:0072659 | 57 | 0.202 | |
| regulation of mapk cascade | GO:0043408 | 248 | 0.198 | |
| nucleobase containing small molecule metabolic process | GO:0055086 | 352 | 0.197 | Rat |
| microtubule cytoskeleton organization | GO:0000226 | 157 | 0.194 | |
| regulation of cell adhesion | GO:0030155 | 154 | 0.193 | Mouse |
| regulation of purine nucleotide metabolic process | GO:1900542 | 169 | 0.192 | |
| positive regulation of protein kinase activity | GO:0045860 | 144 | 0.186 | |
| positive regulation of cell migration | GO:0030335 | 109 | 0.186 | Human Mouse |
| purine nucleotide metabolic process | GO:0006163 | 302 | 0.185 | Rat |
| atp catabolic process | GO:0006200 | 55 | 0.182 | Rat |
| leukocyte differentiation | GO:0002521 | 342 | 0.176 | |
| positive regulation of protein phosphorylation | GO:0001934 | 242 | 0.176 | |
| positive regulation of protein serine threonine kinase activity | GO:0071902 | 106 | 0.176 | |
| regulation of cell substrate adhesion | GO:0010810 | 73 | 0.176 | |
| nuclear division | GO:0000280 | 158 | 0.175 | |
| regulation of cellular component biogenesis | GO:0044087 | 181 | 0.173 | Human |
| cell matrix adhesion | GO:0007160 | 68 | 0.173 | |
| purine ribonucleotide catabolic process | GO:0009154 | 208 | 0.171 | Rat |
| cellular ketone metabolic process | GO:0042180 | 84 | 0.171 | |
| myosin filament assembly | GO:0031034 | 2 | 0.167 | |
| ribonucleoside monophosphate catabolic process | GO:0009158 | 57 | 0.159 | Rat |
| macromolecule catabolic process | GO:0009057 | 281 | 0.159 | |
| organic cyclic compound catabolic process | GO:1901361 | 295 | 0.158 | Rat |
| positive regulation of protein modification process | GO:0031401 | 299 | 0.156 | |
| gland development | GO:0048732 | 330 | 0.156 | |
| protein targeting | GO:0006605 | 143 | 0.154 | Human |
| negative regulation of cellular component organization | GO:0051129 | 194 | 0.153 | |
| microtubule based process | GO:0007017 | 236 | 0.152 | |
| synaptic transmission | GO:0007268 | 329 | 0.145 | |
| guanosine containing compound metabolic process | GO:1901068 | 144 | 0.142 | |
| cell cell junction organization | GO:0045216 | 72 | 0.140 | Human |
| regulation of cytoskeleton organization | GO:0051493 | 122 | 0.140 | Mouse |
| cation homeostasis | GO:0055080 | 212 | 0.140 | |
| ribose phosphate metabolic process | GO:0019693 | 291 | 0.140 | Rat |
| negative regulation of phosphorylation | GO:0042326 | 166 | 0.140 | |
| gtp catabolic process | GO:0006184 | 143 | 0.137 | |
| sphingolipid metabolic process | GO:0006665 | 45 | 0.136 | |
| single organism cell adhesion | GO:0098602 | 156 | 0.135 | |
| substrate dependent cell migration | GO:0006929 | 18 | 0.134 | |
| regulation of cell projection assembly | GO:0060491 | 38 | 0.134 | |
| lamellipodium organization | GO:0097581 | 29 | 0.132 | |
| purine ribonucleoside triphosphate catabolic process | GO:0009207 | 199 | 0.131 | Rat |
| response to peptide | GO:1901652 | 136 | 0.130 | |
| response to growth factor | GO:0070848 | 198 | 0.129 | Human |
| cellular response to growth factor stimulus | GO:0071363 | 197 | 0.127 | Human |
| mitotic cell cycle process | GO:1903047 | 159 | 0.127 | |
| regulation of cell motility | GO:2000145 | 236 | 0.126 | Human Mouse |
| endocytosis | GO:0006897 | 168 | 0.126 | |
| nucleoside monophosphate metabolic process | GO:0009123 | 85 | 0.125 | Rat |
| regulation of endocytic recycling | GO:2001135 | 3 | 0.125 | |
| regulation of organelle organization | GO:0033043 | 289 | 0.121 | Mouse |
| negative regulation of phosphate metabolic process | GO:0045936 | 184 | 0.121 | |
| gtp metabolic process | GO:0046039 | 144 | 0.118 | |
| positive regulation of cell development | GO:0010720 | 237 | 0.118 | |
| positive regulation of necrotic cell death | GO:0010940 | 1 | 0.118 | |
| syncytium formation by plasma membrane fusion | GO:0000768 | 42 | 0.117 | |
| protein localization to organelle | GO:0033365 | 185 | 0.116 | |
| cell substrate adhesion | GO:0031589 | 130 | 0.115 | |
| establishment of protein localization to membrane | GO:0090150 | 54 | 0.113 | Human |
| cellular response to hepatocyte growth factor stimulus | GO:0035729 | 2 | 0.112 | |
| peptidyl serine modification | GO:0018209 | 83 | 0.112 | |
| regulation of protein targeting | GO:1903533 | 61 | 0.112 | Human |
| maintenance of location | GO:0051235 | 89 | 0.111 | |
| positive regulation of cholesterol storage | GO:0010886 | 3 | 0.111 | |
| amine metabolic process | GO:0009308 | 45 | 0.109 | |
| body morphogenesis | GO:0010171 | 45 | 0.109 | |
| tissue remodeling | GO:0048771 | 102 | 0.106 | |
| platelet activation | GO:0030168 | 40 | 0.106 | |
| organelle fission | GO:0048285 | 170 | 0.105 | |
| developmental growth involved in morphogenesis | GO:0060560 | 138 | 0.104 | |
| regulation of anatomical structure size | GO:0090066 | 178 | 0.104 | |
| divalent inorganic cation homeostasis | GO:0072507 | 138 | 0.103 | |
| mesoderm development | GO:0007498 | 100 | 0.101 | Fly |
| jnk cascade | GO:0007254 | 72 | 0.100 | |
| neuron projection extension | GO:1990138 | 64 | 0.099 | |
| positive regulation of growth | GO:0045927 | 104 | 0.099 | |
| ion transmembrane transport | GO:0034220 | 361 | 0.099 | |
| guanosine containing compound catabolic process | GO:1901069 | 144 | 0.098 | |
| cellular response to peptide | GO:1901653 | 92 | 0.098 | |
| cell growth | GO:0016049 | 130 | 0.097 | |
| regulation of protein localization | GO:0032880 | 231 | 0.097 | Human |
| response to amino acid | GO:0043200 | 37 | 0.097 | |
| calcium ion homeostasis | GO:0055074 | 127 | 0.097 | |
| negative regulation of organelle organization | GO:0010639 | 90 | 0.096 | |
| establishment of protein localization to plasma membrane | GO:0090002 | 34 | 0.095 | |
| mitotic nuclear division | GO:0007067 | 48 | 0.095 | |
| regulation of transferase activity | GO:0051338 | 263 | 0.094 | |
| metal ion homeostasis | GO:0055065 | 189 | 0.093 | |
| negative regulation of phosphorus metabolic process | GO:0010563 | 184 | 0.093 | |
| embryonic organ morphogenesis | GO:0048562 | 276 | 0.092 | |
| ribonucleoside catabolic process | GO:0042454 | 206 | 0.090 | Rat |
| response to oxygen levels | GO:0070482 | 62 | 0.090 | |
| regulation of cell projection organization | GO:0031344 | 206 | 0.089 | |
| negative regulation of apoptotic signaling pathway | GO:2001234 | 104 | 0.089 | |
| blood vessel endothelial cell migration | GO:0043534 | 23 | 0.088 | |
| urogenital system development | GO:0001655 | 261 | 0.088 | Mouse |
| erk1 and erk2 cascade | GO:0070371 | 77 | 0.088 | |
| skeletal muscle fiber development | GO:0048741 | 58 | 0.088 | |
| regulation of cellular amino acid metabolic process | GO:0006521 | 5 | 0.088 | |
| regulation of striated muscle cell differentiation | GO:0051153 | 81 | 0.088 | |
| t cell activation | GO:0042110 | 289 | 0.087 | |
| schwann cell development | GO:0014044 | 22 | 0.087 | |
| response to peptide hormone | GO:0043434 | 127 | 0.085 | |
| establishment of protein localization to organelle | GO:0072594 | 118 | 0.084 | |
| cell junction assembly | GO:0034329 | 52 | 0.084 | Human |
| regulation of actin filament polymerization | GO:0030833 | 38 | 0.084 | |
| male gamete generation | GO:0048232 | 285 | 0.083 | |
| gastrulation | GO:0007369 | 116 | 0.080 | |
| cytoplasmic transport | GO:0016482 | 234 | 0.079 | |
| leukocyte proliferation | GO:0070661 | 172 | 0.079 | |
| myeloid cell differentiation | GO:0030099 | 233 | 0.078 | |
| regulation of cellular component size | GO:0032535 | 121 | 0.077 | |
| developmental maturation | GO:0021700 | 193 | 0.077 | |
| cholesterol storage | GO:0010878 | 4 | 0.077 | |
| striated muscle myosin thick filament assembly | GO:0071688 | 1 | 0.077 | |
| regulation of actin filament length | GO:0030832 | 45 | 0.076 | |
| regulation of neuron projection development | GO:0010975 | 169 | 0.076 | |
| divalent inorganic cation transport | GO:0072511 | 178 | 0.076 | |
| regulation of cell cycle process | GO:0010564 | 160 | 0.074 | |
| plasma membrane organization | GO:0007009 | 90 | 0.074 | |
| regulation of wound healing | GO:0061041 | 40 | 0.073 | |
| regulation of purine nucleotide catabolic process | GO:0033121 | 122 | 0.073 | |
| small gtpase mediated signal transduction | GO:0007264 | 97 | 0.071 | |
| regulation of system process | GO:0044057 | 200 | 0.071 | |
| regulation of myotube differentiation | GO:0010830 | 62 | 0.070 | |
| leukocyte migration | GO:0050900 | 124 | 0.070 | |
| muscle tissue development | GO:0060537 | 308 | 0.070 | |
| glial cell differentiation | GO:0010001 | 131 | 0.069 | |
| transmembrane receptor protein tyrosine kinase signaling pathway | GO:0007169 | 247 | 0.069 | Human Mouse |
| cell chemotaxis | GO:0060326 | 81 | 0.069 | |
| regulation of homeostatic process | GO:0032844 | 182 | 0.069 | |
| positive regulation of mapk cascade | GO:0043410 | 170 | 0.068 | |
| respiratory tube development | GO:0030323 | 167 | 0.068 | |
| regulation of vesicle mediated transport | GO:0060627 | 139 | 0.067 | |
| peptidyl serine phosphorylation | GO:0018105 | 74 | 0.067 | |
| regulation of lamellipodium morphogenesis | GO:2000392 | 1 | 0.067 | |
| sensory organ morphogenesis | GO:0090596 | 242 | 0.067 | |
| transmembrane transport | GO:0055085 | 412 | 0.067 | |
| epidermis development | GO:0008544 | 187 | 0.067 | |
| spermatogenesis | GO:0007283 | 284 | 0.065 | |
| camera type eye development | GO:0043010 | 266 | 0.065 | |
| renal system development | GO:0072001 | 225 | 0.065 | Mouse |
| regulation of ion transport | GO:0043269 | 215 | 0.065 | |
| regulation of cell shape | GO:0008360 | 39 | 0.064 | |
| extracellular structure organization | GO:0043062 | 148 | 0.064 | Mouse |
| meiotic cell cycle | GO:0051321 | 122 | 0.064 | |
| dna metabolic process | GO:0006259 | 303 | 0.063 | |
| sequestering of calcium ion | GO:0051208 | 18 | 0.063 | |
| protein processing | GO:0016485 | 163 | 0.063 | |
| regulation of map kinase activity | GO:0043405 | 120 | 0.062 | |
| cellular chemical homeostasis | GO:0055082 | 215 | 0.062 | |
| exocytosis | GO:0006887 | 121 | 0.062 | Mouse |
| multicellular organismal homeostasis | GO:0048871 | 164 | 0.062 | |
| positive regulation of endocytic recycling | GO:2001137 | 2 | 0.061 | |
| fatty acid transmembrane transport | GO:1902001 | 1 | 0.061 | |
| protein maturation | GO:0051604 | 176 | 0.060 | |
| endothelial cell migration | GO:0043542 | 44 | 0.060 | |
| regulation of cell cycle | GO:0051726 | 281 | 0.059 | |
| germ cell development | GO:0007281 | 185 | 0.059 | |
| regulation of nucleoside metabolic process | GO:0009118 | 130 | 0.059 | |
| fibrinolysis | GO:0042730 | 3 | 0.059 | |
| regulation of angiogenesis | GO:0045765 | 81 | 0.059 | |
| positive regulation of cell projection organization | GO:0031346 | 95 | 0.059 | |
| negative regulation of protein complex disassembly | GO:0043242 | 22 | 0.058 | |
| skeletal muscle organ development | GO:0060538 | 163 | 0.058 | |
| mitochondrion organization | GO:0007005 | 134 | 0.058 | |
| peptidyl amino acid modification | GO:0018193 | 336 | 0.058 | |
| circulatory system process | GO:0003013 | 197 | 0.058 | |
| establishment of organelle localization | GO:0051656 | 122 | 0.057 | |
| positive regulation of cytoplasmic transport | GO:1903651 | 40 | 0.057 | |
| positive regulation of cell death | GO:0010942 | 224 | 0.057 | |
| negative regulation of protein metabolic process | GO:0051248 | 282 | 0.057 | |
| wnt signaling pathway | GO:0016055 | 188 | 0.056 | |
| reactive oxygen species metabolic process | GO:0072593 | 84 | 0.056 | |
| positive regulation of organelle organization | GO:0010638 | 128 | 0.056 | |
| t cell differentiation | GO:0030217 | 174 | 0.055 | |
| nuclear membrane organization | GO:0071763 | 4 | 0.055 | |
| dendrite development | GO:0016358 | 115 | 0.055 | |
| axonogenesis | GO:0007409 | 274 | 0.054 | |
| muscle contraction | GO:0006936 | 101 | 0.054 | |
| striated muscle tissue development | GO:0014706 | 293 | 0.054 | |
| regulation of t cell activation | GO:0050863 | 170 | 0.054 | |
| positive regulation of map kinase activity | GO:0043406 | 84 | 0.053 | |
| myotube cell development | GO:0014904 | 60 | 0.053 | |
| mapk cascade | GO:0000165 | 281 | 0.053 | |
| actin filament polymerization | GO:0030041 | 44 | 0.053 | |
| regulation of cytokine production | GO:0001817 | 266 | 0.053 | |
| axon ensheathment | GO:0008366 | 76 | 0.052 | |
| positive regulation of cell cycle | GO:0045787 | 92 | 0.052 | |
| negative regulation of molecular function | GO:0044092 | 258 | 0.052 | |
| chemotaxis | GO:0006935 | 247 | 0.051 | |
| reactive nitrogen species metabolic process | GO:2001057 | 0 | 0.051 | |
| engulfment of apoptotic cell | GO:0043652 | 3 | 0.051 | |
| regulation of syncytium formation by plasma membrane fusion | GO:0060142 | 23 | 0.051 | |
| adult behavior | GO:0030534 | 135 | 0.051 | |
| regulation of sequence specific dna binding transcription factor activity | GO:0051090 | 106 | 0.051 | |
| regulation of cytoplasmic transport | GO:1903649 | 112 | 0.051 | |
| positive regulation of nucleotide metabolic process | GO:0045981 | 114 | 0.050 | |
| carbohydrate derivative biosynthetic process | GO:1901137 | 183 | 0.050 | |
| positive regulation of cell activation | GO:0050867 | 158 | 0.050 | |
| negative regulation of intracellular signal transduction | GO:1902532 | 167 | 0.050 | |
| protein kinase b signaling | GO:0043491 | 74 | 0.050 | |
| platelet derived growth factor receptor signaling pathway | GO:0048008 | 32 | 0.049 | Mouse |
| cell type specific apoptotic process | GO:0097285 | 268 | 0.049 | |
| ribonucleoside monophosphate metabolic process | GO:0009161 | 80 | 0.049 | Rat |
| cellular response to carbohydrate stimulus | GO:0071322 | 50 | 0.049 | |
| positive regulation of nf kappab transcription factor activity | GO:0051092 | 30 | 0.049 | |
| divalent metal ion transport | GO:0070838 | 172 | 0.048 | |
| cytokine mediated signaling pathway | GO:0019221 | 115 | 0.048 | |
| cellular response to peptide hormone stimulus | GO:0071375 | 92 | 0.048 | |
| regulation of nucleotide metabolic process | GO:0006140 | 169 | 0.048 | |
| purine ribonucleoside monophosphate catabolic process | GO:0009169 | 57 | 0.048 | Rat |
| regulation of apoptotic signaling pathway | GO:2001233 | 197 | 0.047 | |
| blood coagulation | GO:0007596 | 76 | 0.047 | |
| regulation of erk1 and erk2 cascade | GO:0070372 | 71 | 0.047 | |
| negative regulation of protein modification process | GO:0031400 | 163 | 0.047 | |
| cell substrate adherens junction assembly | GO:0007045 | 19 | 0.047 | |
| negative regulation of cellular protein metabolic process | GO:0032269 | 247 | 0.047 | |
| regulation of lymphocyte activation | GO:0051249 | 240 | 0.046 | |
| regulation of gtp catabolic process | GO:0033124 | 113 | 0.046 | |
| purine ribonucleoside monophosphate metabolic process | GO:0009167 | 80 | 0.046 | Rat |
| regulation of membrane potential | GO:0042391 | 192 | 0.046 | |
| neuronal action potential | GO:0019228 | 54 | 0.046 | |
| negative regulation of cytoskeleton organization | GO:0051494 | 36 | 0.046 | |
| cellular homeostasis | GO:0019725 | 240 | 0.045 | |
| cellular lipid metabolic process | GO:0044255 | 323 | 0.045 | |
| phospholipid metabolic process | GO:0006644 | 87 | 0.045 | |
| extrinsic apoptotic signaling pathway | GO:0097191 | 126 | 0.045 | |
| response to organonitrogen compound | GO:0010243 | 246 | 0.045 | |
| developmental cell growth | GO:0048588 | 84 | 0.045 | |
| cell maturation | GO:0048469 | 127 | 0.045 | |
| cell fate commitment | GO:0045165 | 210 | 0.045 | |
| b cell activation | GO:0042113 | 161 | 0.044 | |
| stress activated mapk cascade | GO:0051403 | 80 | 0.044 | |
| actin filament bundle assembly | GO:0051017 | 40 | 0.044 | |
| angiogenesis | GO:0001525 | 201 | 0.044 | |
| cardiac myofibril assembly | GO:0055003 | 12 | 0.044 | |
| hair cycle | GO:0042633 | 90 | 0.044 | |
| regulation of protein transport | GO:0051223 | 163 | 0.043 | Human |
| apical junction assembly | GO:0043297 | 15 | 0.043 | Human |
| regulation of cell activation | GO:0050865 | 289 | 0.043 | |
| protein autophosphorylation | GO:0046777 | 61 | 0.043 | |
| lymphocyte differentiation | GO:0030098 | 242 | 0.043 | |
| spermatid development | GO:0007286 | 108 | 0.042 | |
| positive regulation of sequence specific dna binding transcription factor activity | GO:0051091 | 68 | 0.042 | |
| spermatid differentiation | GO:0048515 | 115 | 0.042 | |
| positive regulation of kinase activity | GO:0033674 | 155 | 0.042 | |
| cellular response to organonitrogen compound | GO:0071417 | 145 | 0.042 | |
| establishment of vesicle localization | GO:0051650 | 81 | 0.041 | |
| phagocytosis | GO:0006909 | 66 | 0.041 | |
| g protein coupled acetylcholine receptor signaling pathway | GO:0007213 | 4 | 0.041 | |
| establishment or maintenance of cell polarity | GO:0007163 | 86 | 0.041 | |
| peptidyl tyrosine modification | GO:0018212 | 145 | 0.041 | |
| negative regulation of cellular amino acid metabolic process | GO:0045763 | 0 | 0.041 | |
| protein localization to nucleus | GO:0034504 | 121 | 0.041 | |
| action potential | GO:0001508 | 78 | 0.041 | |
| immune effector process | GO:0002252 | 321 | 0.041 | Mouse |
| myeloid leukocyte differentiation | GO:0002573 | 119 | 0.040 | |
| ensheathment of neurons | GO:0007272 | 76 | 0.040 | |
| peptidyl tyrosine phosphorylation | GO:0018108 | 143 | 0.040 | |
| mitotic cell cycle | GO:0000278 | 195 | 0.040 | |
| sarcomere organization | GO:0045214 | 24 | 0.039 | |
| organonitrogen compound biosynthetic process | GO:1901566 | 192 | 0.039 | |
| cellular metal ion homeostasis | GO:0006875 | 151 | 0.039 | |
| positive regulation of apoptotic signaling pathway | GO:2001235 | 95 | 0.039 | |
| positive regulation of syncytium formation by plasma membrane fusion | GO:0060143 | 17 | 0.039 | |
| negative regulation of immune system process | GO:0002683 | 209 | 0.038 | |
| positive regulation of neuron projection development | GO:0010976 | 79 | 0.038 | |
| lipid biosynthetic process | GO:0008610 | 179 | 0.038 | |
| development of primary sexual characteristics | GO:0045137 | 143 | 0.038 | |
| meiotic nuclear division | GO:0007126 | 115 | 0.038 | |
| vesicle localization | GO:0051648 | 86 | 0.038 | |
| lymphocyte proliferation | GO:0046651 | 164 | 0.038 | |
| glycerophospholipid metabolic process | GO:0006650 | 71 | 0.037 | |
| regulation of cysteine type endopeptidase activity involved in apoptotic process | GO:0043281 | 62 | 0.037 | |
| stem cell differentiation | GO:0048863 | 268 | 0.037 | |
| positive regulation of apoptotic process | GO:0043065 | 217 | 0.037 | |
| regulation of blood vessel endothelial cell migration | GO:0043535 | 12 | 0.037 | |
| regulation of metal ion transport | GO:0010959 | 106 | 0.037 | |
| positive regulation of ion transport | GO:0043270 | 65 | 0.036 | |
| regulation of endocytosis | GO:0030100 | 69 | 0.036 | |
| stress activated protein kinase signaling cascade | GO:0031098 | 81 | 0.036 | |
| purine nucleoside monophosphate metabolic process | GO:0009126 | 81 | 0.036 | Rat |
| regulation of cellular catabolic process | GO:0031329 | 242 | 0.036 | |
| negative regulation of cell adhesion | GO:0007162 | 45 | 0.035 | Mouse |
| positive regulation of homeostatic process | GO:0032846 | 64 | 0.035 | |
| innate immune response | GO:0045087 | 157 | 0.035 | Mouse |
| regulation of embryonic development | GO:0045995 | 71 | 0.035 | |
| lamellipodium morphogenesis | GO:0072673 | 5 | 0.035 | |
| positive regulation of cytoskeleton organization | GO:0051495 | 49 | 0.035 | |
| positive regulation of muscle cell differentiation | GO:0051149 | 39 | 0.035 | |
| positive regulation of reactive oxygen species metabolic process | GO:2000379 | 11 | 0.034 | |
| positive regulation of nucleotide catabolic process | GO:0030813 | 88 | 0.034 | |
| regulation of ras protein signal transduction | GO:0046578 | 114 | 0.034 | |
| heart process | GO:0003015 | 94 | 0.034 | |
| response to oxidative stress | GO:0006979 | 123 | 0.034 | |
| glycoprotein biosynthetic process | GO:0009101 | 89 | 0.034 | |
| regulation of hippo signaling | GO:0035330 | 1 | 0.034 | |
| protein targeting to plasma membrane | GO:0072661 | 7 | 0.034 | |
| positive regulation of transferase activity | GO:0051347 | 167 | 0.034 | |
| cell aging | GO:0007569 | 35 | 0.034 | |
| cellular response to cytokine stimulus | GO:0071345 | 189 | 0.034 | |
| modification dependent macromolecule catabolic process | GO:0043632 | 133 | 0.034 | |
| coagulation | GO:0050817 | 78 | 0.033 | |
| alpha beta t cell activation | GO:0046631 | 91 | 0.033 | |
| regulation of lymphocyte differentiation | GO:0045619 | 107 | 0.033 | |
| multicellular organismal signaling | GO:0035637 | 91 | 0.033 | |
| regulation of reactive oxygen species biosynthetic process | GO:1903426 | 2 | 0.033 | |
| regulation of reactive oxygen species metabolic process | GO:2000377 | 40 | 0.033 | |
| regulation of actin polymerization or depolymerization | GO:0008064 | 45 | 0.033 | |
| focal adhesion assembly | GO:0048041 | 19 | 0.033 | |
| positive regulation of nervous system development | GO:0051962 | 221 | 0.033 | |
| actin filament based movement | GO:0030048 | 23 | 0.032 | |
| regulation of intracellular protein transport | GO:0033157 | 82 | 0.032 | Human |
| mitotic cytokinesis | GO:0000281 | 4 | 0.032 | |
| epithelial cell migration | GO:0010631 | 63 | 0.032 | |
| regulation of cell morphogenesis involved in differentiation | GO:0010769 | 151 | 0.032 | |
| positive regulation of proteolysis | GO:0045862 | 85 | 0.032 | |
| cellular divalent inorganic cation homeostasis | GO:0072503 | 127 | 0.032 | |
| regulation of endothelial cell migration | GO:0010594 | 22 | 0.032 | |
| organic acid transport | GO:0015849 | 101 | 0.032 | |
| actin cytoskeleton reorganization | GO:0031532 | 21 | 0.031 | |
| anion transmembrane transport | GO:0098656 | 71 | 0.031 | |
| response to organic cyclic compound | GO:0014070 | 198 | 0.031 | |
| interleukin 13 secretion | GO:0072611 | 2 | 0.031 | |
| leukocyte activation involved in immune response | GO:0002366 | 126 | 0.031 | Mouse |
| integrin mediated signaling pathway | GO:0007229 | 27 | 0.031 | |
| cellular response to inorganic substance | GO:0071241 | 37 | 0.031 | |
| heart contraction | GO:0060047 | 93 | 0.031 | |
| response to hepatocyte growth factor | GO:0035728 | 2 | 0.031 | |
| immune response activating signal transduction | GO:0002757 | 116 | 0.031 | |
| glycerolipid biosynthetic process | GO:0045017 | 50 | 0.031 | |
| response to decreased oxygen levels | GO:0036293 | 59 | 0.031 | |
| regulation of transmembrane receptor protein serine threonine kinase signaling pathway | GO:0090092 | 112 | 0.030 | |
| organelle localization | GO:0051640 | 179 | 0.030 | |
| microglia differentiation | GO:0014004 | 2 | 0.030 | |
| meiotic cell cycle process | GO:1903046 | 77 | 0.030 | |
| regulation of extrinsic apoptotic signaling pathway | GO:2001236 | 77 | 0.030 | |
| regulation of response to wounding | GO:1903034 | 189 | 0.030 | |
| morphogenesis of a branching epithelium | GO:0061138 | 193 | 0.030 | |
| sulfur compound metabolic process | GO:0006790 | 100 | 0.030 | |
| osteoclast differentiation | GO:0030316 | 62 | 0.030 | |
| cellular ion homeostasis | GO:0006873 | 165 | 0.030 | |
| protein catabolic process | GO:0030163 | 221 | 0.029 | |
| mammary gland morphogenesis | GO:0060443 | 54 | 0.029 | |
| protein targeting to membrane | GO:0006612 | 20 | 0.029 | Human |
| extracellular matrix organization | GO:0030198 | 147 | 0.029 | Mouse |
| cardiac muscle contraction | GO:0060048 | 32 | 0.029 | |
| regulation of nucleotide catabolic process | GO:0030811 | 122 | 0.029 | |
| plasma membrane long chain fatty acid transport | GO:0015911 | 1 | 0.029 | |
| t cell proliferation | GO:0042098 | 120 | 0.029 | |
| anion transport | GO:0006820 | 177 | 0.029 | |
| cellular protein complex assembly | GO:0043623 | 116 | 0.029 | |
| regulation of skeletal muscle fiber development | GO:0048742 | 36 | 0.029 | |
| regulation of cellular response to stress | GO:0080135 | 159 | 0.029 | |
| stem cell development | GO:0048864 | 219 | 0.029 | |
| cellular calcium ion homeostasis | GO:0006874 | 119 | 0.029 | |
| glial cell development | GO:0021782 | 54 | 0.029 | |
| cellularization | GO:0007349 | 1 | 0.028 | |
| regulation of proteolysis | GO:0030162 | 164 | 0.028 | |
| cognition | GO:0050890 | 149 | 0.028 | |
| homotypic cell cell adhesion | GO:0034109 | 28 | 0.028 | |
| establishment or maintenance of bipolar cell polarity | GO:0061245 | 21 | 0.028 | |
| single organism nuclear import | GO:1902593 | 95 | 0.028 | |
| g1 s transition of mitotic cell cycle | GO:0000082 | 57 | 0.028 | |
| regulation of defense response | GO:0031347 | 233 | 0.028 | Mouse |
| epithelium migration | GO:0090132 | 63 | 0.028 | |
| negative regulation of release of cytochrome c from mitochondria | GO:0090201 | 6 | 0.028 | |
| retina development in camera type eye | GO:0060041 | 119 | 0.028 | |
| protein polymerization | GO:0051258 | 57 | 0.028 | |
| intrinsic apoptotic signaling pathway | GO:0097193 | 132 | 0.027 | |
| negative regulation of peptidase activity | GO:0010466 | 46 | 0.027 | |
| lung development | GO:0030324 | 164 | 0.027 | |
| regulation of cysteine type endopeptidase activity | GO:2000116 | 65 | 0.027 | |
| cytosolic calcium ion transport | GO:0060401 | 48 | 0.027 | |
| response to inorganic substance | GO:0010035 | 96 | 0.027 | |
| adherens junction assembly | GO:0034333 | 22 | 0.027 | |
| negative regulation of cell proliferation | GO:0008285 | 296 | 0.027 | |
| regulation of transmembrane transport | GO:0034762 | 128 | 0.027 | |
| cellular response to abiotic stimulus | GO:0071214 | 56 | 0.027 | |
| activation of mapk activity | GO:0000187 | 59 | 0.027 | |
| g protein coupled receptor signaling pathway | GO:0007186 | 243 | 0.027 | |
| chronological cell aging | GO:0001300 | 1 | 0.027 | |
| positive regulation of intracellular transport | GO:0032388 | 70 | 0.027 | Human |
| female gamete generation | GO:0007292 | 74 | 0.027 | |
| adaptive immune response | GO:0002250 | 155 | 0.026 | |
| regulation of ion transmembrane transport | GO:0034765 | 119 | 0.026 | |
| modification dependent protein catabolic process | GO:0019941 | 133 | 0.026 | |
| regulation of protein processing | GO:0070613 | 96 | 0.026 | |
| antigen processing and presentation | GO:0019882 | 47 | 0.026 | |
| positive regulation of purine nucleotide catabolic process | GO:0033123 | 88 | 0.026 | |
| regulation of cell division | GO:0051302 | 76 | 0.026 | |
| myelination | GO:0042552 | 74 | 0.026 | |
| regulation of stress fiber assembly | GO:0051492 | 15 | 0.026 | |
| lipid localization | GO:0010876 | 126 | 0.026 | |
| organic anion transport | GO:0015711 | 137 | 0.026 | |
| response to muscle stretch | GO:0035994 | 1 | 0.026 | |
| cell division | GO:0051301 | 120 | 0.026 | |
| response to epidermal growth factor | GO:0070849 | 4 | 0.026 | |